A world-first complete remission of pituitary cancer has been achieved by using genomic "blueprints" to match patients with the right immunotherapy clinical trials.
Most Recent Articles
Enzymatic Modulation of the Retinal Barrier Enhances Stem Cell-Derived Neuron Survival
Researchers have cleared a path for vision restoration by disrupting a "hidden" retinal barrier that previously blocked transplanted nerve cells from healing the eye
Beyond Radiological Reads: Tracking Pre-Symptomatic AD Brain Signatures
A new neuroimaging "map" allows routine MRI scans to detect Alzheimer's disease risks in patients as young as thirty, years before memory loss begins.
Evidence-Based Analysis of Botox and Oral Medications for High-Frequency Headache
Comprehensive review of 43 clinical trials identifies CGRP-targeted drugs as the superior choice for reducing monthly headache days in patients suffering from chronic migraines.
Targeting the Vascular Marginated Neutrophil Pool to Enhance Post-Infarct Healing
A hidden reserve of immune cells on blood vessel walls triggers a "fight or flight" surge that damages the heart post-infarction, but temporary beta-blockade may stop it.